2026 NPPES data Dermatology Physician NPI 1487739413 M.D.
Verify on CMS →

STUART BITTERMAN, M.D.

Dermatology Physician in FOREST HILLS, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
192
Medicare Part D claims · Dermatology Physician avg: 729
Generic prescribing
36%
generic claims · 64% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

STUART BITTERMAN, M.D. filed 192 Medicare Part D claims in 2023 as a Dermatology Physician in FOREST HILLS, New York, prescribing 36% generic.

192
Part D claims, 2023
36%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

STUART BITTERMAN, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

192 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

STUART BITTERMAN, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about STUART BITTERMAN, M.D.?

Quality data not reported

NPI registry status

Active

Issued 10/26/2006

NPI 1487739413

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

192 74% vs specialty avg

2023 prescription claims

Specialty avg: 729

Specialty distribution in New York

How Dermatology Physician compares to other specialties among New York providers

New York providers

Dermatology Physician share within New York

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Dermatology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Dermatology Physician ABMS/AOA estimate

Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

STUART BITTERMAN, M.D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M.D. credentials at 7734 113TH ST, FOREST HILLS, NY, 11375, with a listed phone of (718) 544-6650. NPI 1487739413 was issued on 10/26/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BITTERMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 192 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $89K in drug spend, split 64% brand-name and 36% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

7734 113TH ST
FOREST HILLS, NY 11375

Provider Details

NPI 1487739413
Specialty Dermatology Physician
Credentials M.D.
Gender Male
NPI Issued 10/26/2006

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to STUART BITTERMAN, M.D.. To verify STUART BITTERMAN, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

STUART BITTERMAN, M.D. — brand share 64.0%
Specialty average (est.)

64% brand-name claims vs 36% generic, on 192 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

192
Total Claims
$89K
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
193
Total Day Supply
5,414
Brand vs Generic
64% brand / 36% generic
Brand Drug Cost
$76K
Generic Drug Cost
$14K
Antibiotic Claims
11

Patient Demographics

Average Patient Age
72.8 years
Avg HCC Risk Score
1.23

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What STUART BITTERMAN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Rybelsus
Semaglutide
14
Verquvo
Vericiguat
14
Coreg Cr
Carvedilol Phosphate
13
Cozaar
Losartan Potassium
13
Crestor
Rosuvastatin Calcium
13
Eliquis
Apixaban
13
Entresto
Sacubitril/Valsartan
13
Jardiance
Empagliflozin
13
Lovaza
Omega-3 Acid Ethyl Esters
13
Multaq
Dronedarone Hcl
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How STUART BITTERMAN, M.D. fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

STUART BITTERMAN, M.D.'s 192 claims are below the specialty average of 729.

Nearby Dermatology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as BITTERMAN.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is STUART BITTERMAN, M.D.'s specialty?
STUART BITTERMAN, M.D. specializes in Dermatology Physician and practices in FOREST HILLS, New York. Credentials: M.D..
How much does STUART BITTERMAN, M.D. prescribe under Medicare Part D?
In 2023, STUART BITTERMAN, M.D. wrote 192 Medicare Part D claims totaling $89K in drug costs for N/A beneficiaries.
Where is STUART BITTERMAN, M.D. located?
STUART BITTERMAN, M.D. is located at 7734 113TH ST, FOREST HILLS, NY, 11375. Phone: (718) 544-6650.
What is STUART BITTERMAN, M.D.'s NPI number?
STUART BITTERMAN, M.D.'s National Provider Identifier (NPI) is 1487739413, issued on 10/26/2006.
Does STUART BITTERMAN, M.D. prescribe more brand-name or generic drugs?
STUART BITTERMAN, M.D.'s prescribing is 64% brand-name and 36% generic drugs by claim count, with $76K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does STUART BITTERMAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, STUART BITTERMAN, M.D.'s most frequently prescribed drugs include Rybelsus, Verquvo, Coreg Cr. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does STUART BITTERMAN, M.D. accept Medicare?
STUART BITTERMAN, M.D. appears in CMS Medicare data with 192 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify STUART BITTERMAN, M.D.'s credentials?
STUART BITTERMAN, M.D.'s NPI is 1487739413 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology